Scientists hunt for clues in the brain and blood to understand why clozapine works

NCT ID NCT05316883

Recruiting now Knowledge-focused Sponsor: Jimmi Nielsen Source: ClinicalTrials.gov ↗

First seen Jan 31, 2026 · Last updated May 22, 2026 · Updated 12 times

Summary

This study aims to find biological markers in people with treatment-resistant schizophrenia who respond to the drug clozapine. Researchers will examine 200 participants using brain scans, blood tests, and spinal fluid analysis before and after 12 weeks of treatment. The goal is to better understand why clozapine works for some patients, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

Mental Health Services Glostrup, Unit for Complicated Schizophrenia
RECRUITING

Glostrup Municipality, Denmark, 2600, Denmark

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

PSYCHOSIS SCHIZOPHRENIA